vs
LifeStance Health Group, Inc.（LFST）与Orion Group Holdings Inc（ORN）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Orion Group Holdings Inc的1.8倍（$382.2M vs $216.3M），LifeStance Health Group, Inc.净利率更高（3.1% vs 2.2%，领先0.9%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 14.6%），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 6.1%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
奥里昂集团是源自芬兰的全球化制药企业，1917年成立，总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分，旗下全部生产基地与大部分研发部门均设立在芬兰。
LFST vs ORN — 直观对比
营收规模更大
LFST
是对方的1.8倍
$216.3M
营收增速更快
LFST
高出2.8%
14.6%
净利率更高
LFST
高出0.9%
2.2%
两年增速更快
LFST
近两年复合增速
6.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $216.3M |
| 净利润 | $11.7M | $4.7M |
| 毛利率 | — | 12.0% |
| 营业利润率 | 4.7% | — |
| 净利率 | 3.1% | 2.2% |
| 营收同比 | 17.4% | 14.6% |
| 净利润同比 | 264.1% | 435.7% |
| 每股收益（稀释后） | — | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTORN
| Q1 26 | — | $216.3M | ||
| Q4 25 | $382.2M | $233.2M | ||
| Q3 25 | $363.8M | $225.1M | ||
| Q2 25 | $345.3M | $205.3M | ||
| Q1 25 | $333.0M | $188.7M | ||
| Q4 24 | $325.5M | $216.9M | ||
| Q3 24 | $312.7M | $226.7M | ||
| Q2 24 | $312.3M | $192.2M |
净利润LFSTORN
| Q1 26 | — | $4.7M | ||
| Q4 25 | $11.7M | $-240.0K | ||
| Q3 25 | $1.1M | $3.3M | ||
| Q2 25 | $-3.8M | $841.0K | ||
| Q1 25 | $709.0K | $-1.4M | ||
| Q4 24 | $-7.1M | $6.8M | ||
| Q3 24 | $-6.0M | $4.3M | ||
| Q2 24 | $-23.3M | $-6.6M |
毛利率LFSTORN
| Q1 26 | — | 12.0% | ||
| Q4 25 | — | 11.6% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 9.5% |
营业利润率LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 2.2% | ||
| Q3 25 | 2.0% | 2.4% | ||
| Q2 25 | -0.9% | 1.7% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.3% | 4.4% | ||
| Q3 24 | 0.0% | 3.4% | ||
| Q2 24 | -5.1% | -1.4% |
净利率LFSTORN
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.1% | -0.1% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | -1.1% | 0.4% | ||
| Q1 25 | 0.2% | -0.7% | ||
| Q4 24 | -2.2% | 3.1% | ||
| Q3 24 | -1.9% | 1.9% | ||
| Q2 24 | -7.5% | -3.4% |
每股收益（稀释后）LFSTORN
| Q1 26 | — | $0.12 | ||
| Q4 25 | — | $-0.00 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | — | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $6.3M |
| 总债务越低越好 | $282.8M | — |
| 股东权益账面价值 | $1.5B | $166.7M |
| 总资产 | $2.2B | $478.7M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTORN
| Q1 26 | — | $6.3M | ||
| Q4 25 | $248.6M | $1.6M | ||
| Q3 25 | $203.9M | $4.9M | ||
| Q2 25 | $188.9M | $1.7M | ||
| Q1 25 | $134.3M | $13.0M | ||
| Q4 24 | $154.6M | $28.3M | ||
| Q3 24 | $102.6M | $28.3M | ||
| Q2 24 | $87.0M | $4.8M |
总债务LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | $33.4M | ||
| Q1 25 | $288.2M | $23.3M | ||
| Q4 24 | $290.0M | $23.2M | ||
| Q3 24 | $287.3M | $28.0M | ||
| Q2 24 | $288.0M | $60.3M |
股东权益LFSTORN
| Q1 26 | — | $166.7M | ||
| Q4 25 | $1.5B | $159.0M | ||
| Q3 25 | $1.5B | $157.9M | ||
| Q2 25 | $1.5B | $153.2M | ||
| Q1 25 | $1.5B | $150.8M | ||
| Q4 24 | $1.4B | $150.7M | ||
| Q3 24 | $1.4B | $142.4M | ||
| Q2 24 | $1.4B | $111.1M |
总资产LFSTORN
| Q1 26 | — | $478.7M | ||
| Q4 25 | $2.2B | $414.7M | ||
| Q3 25 | $2.1B | $422.4M | ||
| Q2 25 | $2.1B | $432.7M | ||
| Q1 25 | $2.1B | $416.3M | ||
| Q4 24 | $2.1B | $417.3M | ||
| Q3 24 | $2.1B | $430.3M | ||
| Q2 24 | $2.1B | $414.0M |
负债/权益比LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | 0.22× | ||
| Q1 25 | 0.20× | 0.15× | ||
| Q4 24 | 0.20× | 0.15× | ||
| Q3 24 | 0.20× | 0.20× | ||
| Q2 24 | 0.20× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | — |
| 自由现金流经营现金流 - 资本支出 | $46.6M | — |
| 自由现金流率自由现金流/营收 | 12.2% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 4.93× | — |
| 过去12个月自由现金流最近4个季度 | $110.0M | — |
8季度趋势，按日历期对齐
经营现金流LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | $57.6M | $13.8M | ||
| Q3 25 | $27.3M | $23.3M | ||
| Q2 25 | $64.4M | $-5.6M | ||
| Q1 25 | $-3.1M | $-3.4M | ||
| Q4 24 | $62.3M | $13.4M | ||
| Q3 24 | $22.7M | $37.5M | ||
| Q2 24 | $44.1M | $-15.3M |
自由现金流LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | $46.6M | $454.0K | ||
| Q3 25 | $17.0M | $13.9M | ||
| Q2 25 | $56.6M | $-12.7M | ||
| Q1 25 | $-10.3M | $-12.5M | ||
| Q4 24 | $56.0M | $9.9M | ||
| Q3 24 | $17.7M | $33.3M | ||
| Q2 24 | $39.0M | $-20.0M |
自由现金流率LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | 12.2% | 0.2% | ||
| Q3 25 | 4.7% | 6.2% | ||
| Q2 25 | 16.4% | -6.2% | ||
| Q1 25 | -3.1% | -6.6% | ||
| Q4 24 | 17.2% | 4.6% | ||
| Q3 24 | 5.7% | 14.7% | ||
| Q2 24 | 12.5% | -10.4% |
资本支出强度LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 5.7% | ||
| Q3 25 | 2.8% | 4.2% | ||
| Q2 25 | 2.2% | 3.5% | ||
| Q1 25 | 2.2% | 4.8% | ||
| Q4 24 | 1.9% | 1.6% | ||
| Q3 24 | 1.6% | 1.8% | ||
| Q2 24 | 1.6% | 2.4% |
现金转化率LFSTORN
| Q1 26 | — | — | ||
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | 7.05× | ||
| Q2 25 | — | -6.61× | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 8.79× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
